Boston Scientific Corp (BSX) support and resistance · P/E 20, rev $10.65B
Boston Scientific Corp (BSX) is a medical devices company listed on US.
This page maps Boston Scientific Corp (BSX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new BSX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the BSX quote page for the session range and the stock page for the full model.
Not investment advice.